<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gene expression analysis demonstrated high expression of the neuronal transcription factor SOX11 in mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and reactive lymphoid tissue, most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> tested (48/53 patients) expressed sox11 protein in the nucleus </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore nuclear sox11 expression represents a new <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> marker for a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, 5/53 MCL cases expressed sox11 only in the cytoplasm; these <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> patients had a shorter survival compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> with nuclear sox11 expression </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest sox11 expression as a new diagnostic marker in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> that could be related to the clinical and biological behaviour of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
</text></document>